Home > PJ (current issue) > News Feature | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7418 p332
16 September 2006

This article
Reprint   Photocopy

PDF 30K, Acrobat Reader

News feature

Special interest framework launched

“Super-chemists to take over care of patients from GPs” announced the Daily Mail last week following the launch of a framework to support the establishment of pharmacists with special interests. Dawn Connelly (on the staff of The Journal) looks at the story behind the headline


A National framework for Pharmacists with Special Interests posterWith the Government’s emphasis on moving specialist services from secondary to primary care, a new role for practitioners with specialist interests has emerged. Guidelines for GPs, nurses, dentists, allied health professionals and practice managers have already been published by the Department of Health. Last week, a national framework and guidance to support the establishment of pharmacists with special interests was launched (PJ, 9 September, p299).

A pharmacist with a special interest (PhwSI) is defined as: “Someone who supplements their core generalist role by delivering an additional, high-quality service to meet the needs of patients. Working principally in the community, they deliver a clinical service beyond the scope of their core professional role or may undertake advanced interventions not normally undertaken by their peers. They will have demonstrated appropriate skills and competencies to deliver those services without direct supervision.”

It is not a requirement for PhwSIs to be prescribers but this may enhance the scope of the role in practice, the framework says.

For a pharmacist who would like to become a PhwSI, the first step is to find out from local commissioners whether they intend to commission specific services through PhwSIs as part of service redesign, says Beth Taylor, national development lead for PhwSI at NHS Primary Care Contracting and a member of the PhwSI advisory group.

If services are to be commissioned in this way pharmacists can then gain accreditation by demonstrating competencies in line with the national framework and undergoing a local accreditation process. Full details of the accreditation process will be revealed in further guidance expected later this year. The current system for accrediting GPs with special interests has been reviewed and pharmacists and GPs will in future share the same local accreditation system.

Mrs Taylor explains that PhwSIs must be delivering care direct to patients. “It is not appropriate for pharmacists with a purely leadership role to become PhwSIs,” she says. Practitioners with special interests must also maintain a core generalist role.

Clinical networks

For hospital pharmacists who are already providing a specialist service, for example from an outpatient department, the PhwSI route is optional. Mrs Taylor explains that the PhwSI model has been developed as a quality assurance mechanism for practitioners who work more autonomously. “The idea behind it is that it will make it easier for the commissioners to commission these services,” she says.

However, hospital practitioners should become involved in the development of specialist services in the community. Mrs Taylor would like to see clinical networks developing in which clinical pharmacists and doctors practising in hospitals at an advanced level work with and support pharmacists and others working at a special interest level in primary care.

Mrs Taylor suggests that it would be useful for pharmacists who wish to become PhwSIs to find out whether commissioners in their local health economy have already commissioned services from practitioners with special interests.

There are particular areas, like diabetes, dermatology and sexual health, where it is expected there will be substantial movement of services into primary care. “Those probably present the best opportunities for pharmacists,” Mrs Taylor advises. They are also the sort of opportunities where funding is more likely to be available and where there will be local support from GPs and others, she says.

Competency framework

The document contains a generic competency framework, which takes an approach similar to that used for the establishment of consultant pharmacists in secondary care.

The framework lists two levels of competence — practitioner and pharmacist with a special interest — and six domains. It is intended to help accreditation panels to distinguish between the two roles. PhwSIs must be able to demonstrate all competencies in two clusters (expert professional practice and building working relationships) and the majority of competencies in a further two clusters (leadership and management). The two remaining clusters — training and development and research and evaluation — are optional.

Experience

“We would expect that pharmacists that might aspire to this are already practising in [a specialist] area and may have done some additional training,” explains Mrs Taylor. This training may be sufficient or more training may be necessary to meet the competencies. However, Mrs Taylor predicts that training alone is unlikely to be what is needed to demonstrate competency. “You are almost certainly going to need to demonstrate local experiential learning, such as doing some sessions with a specialist and seeing how certain services are operated,” she says.

The national framework and a step-by-step guide for practitioners who are considering becoming PhwSIs is available on the NHS PCC website. The first PhwSIs are likely to be accredited in 2007.

Established and emerging service models

The national framework gives details of several established and emerging service models similar to PhwSI. The examples listed cover diabetes, substance misuse, anticoagulation, Parkinson’s disease, medicines management for older people, pain management, sexual health and mental health.

A pharmacy service for substance misusers in Northern Lincolnshire illustrates how a PhwSI could provide both a direct patient service and act as a central resource to support a clinical network of pharmacy providers. Tim Cottingham, proprietor of Cottingham Pharmacy, Grimsby, co-ordinates a drug misuse service provided by 43 pharmacies in the area. He has undertaken the Royal College of General Practitioners part 2 certificate in the management of drug misuse and provides telephone support and one-to-one training to other pharmacy staff. The service is well integrated with other providers through weekly meetings with the drug rehabilitation requirements agencies and a quarterly multi-professional forum with all stakeholders.

Mr Cottingham told The Journal: “Becoming accredited as a pharmacist with a special interest is top of my agenda for this year.” He believes that becoming accredited will make it easier for him to take the service forward because he will be taken more seriously at primary care trust level. “At the moment there is nothing that differentiates me from a pharmacist that has not specialised. Becoming accredited will show commissioners that I have made a commitment to a particular disease area.”

He plans to extend the initiative to provide a minor ailments service for drug misusers and their families, which will support the work of a specialist district nurse who regularly visits the pharmacy to treat patients.

Back to Top


©The Pharmaceutical Journal